Equities

Eli Lilly and Co

0Q1G:LSE

Eli Lilly and Co

  • Price (CHF)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,9282,2123,909
Total Receivables, Net11,3368,5598,127
Total Inventory5,7734,3103,886
Prepaid expenses5,5412,9542,531
Other current assets, total150----
Total current assets25,72718,03518,452
Property, plant & equipment, net12,91410,1448,985
Goodwill, net4,9404,0733,892
Intangibles, net6,9077,2077,692
Long term investments3,0522,9023,213
Note receivable - long term------
Other long term assets4,9904,3374,083
Total assets64,00649,49048,806
LIABILITIES
Accounts payable2,5991,9311,671
Accrued expenses13,3399,8447,804
Notes payable/short-term debt6,1891,4980
Current portion long-term debt/capital leases7153.101,538
Other current liabilities, total4,4513,8634,040
Total current liabilities27,29317,13815,053
Total long term debt18,32114,73815,346
Total debt25,22516,23916,885
Deferred income tax--871,734
Minority interest92126176
Other liabilities, total7,5296,7517,518
Total liabilities53,23438,84039,827
SHAREHOLDERS EQUITY
Common stock594594596
Additional paid-in capital7,2506,9216,833
Retained earnings (accumulated deficit)10,31210,0438,959
Treasury stock - common(3057)(3064)(3066)
Unrealized gain (loss)(26)(37)3.70
Other equity, total(4301)(3808)(4347)
Total equity10,77210,6508,979
Total liabilities & shareholders' equity64,00649,49048,806
Total common shares outstanding949950954
Treasury shares - common primary issue0.400.450.46
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.